Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05931913 · ClinicalTrials.gov registry record · NA
TMS + Exposure Therapy for Pediatric OCD
A NA study of Obsessive - Compulsive Disorder, sponsored by Bradley Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 2
- Study locations
NCT05931913: Recruiting NA study of Obsessive - Compulsive Disorder, sponsored by Bradley Hospital.
NCT05931913 is a NA study of Obsessive - Compulsive Disorder that is actively recruiting participants, run by Bradley Hospital. The registered enrollment target is 60 participants, below the 2,064-participant average among 84 other Obsessive - Compulsive Disorder trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05931913, a NA study of Obsessive - Compulsive Disorder, is actively recruiting participants, sponsored by Bradley Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this clinical trial is to compare different forms of transcranial magnetic stimulation (TMS) for improving the outcomes of Exposure with Response Prevention (ERP) in youth and young adults with Obsessive-Compulsive Disorder (OCD). Researchers will compare three groups: ERP with one of two different active ("real") forms of TMS vs. ERP with sham ("fake") TMS. The main questions this study aims to answer are: 1) whether TMS normalizes functioning in brain circuits that contribute to compulsive behavior, and 2) whether TMS reduces compulsions during ERP. Participants will: * Complete clinical interviews, questionnaires, and computerized tasks * Complete two MRIs (brain scans) * Receive daily TMS followed by ERP for two weeks (10 sessions)
Primary Outcome
z-score representing change in resting state connectivity between presupplementary motor area (pSMA) and dorsolateral striatum (DLS)
Conditions Studied
Interventions
- DEVICE Transcranial Magnetic Stimulation: intermittent theta burst to dorsolateral prefrontal cortex
- BEHAVIORAL Exposure with Response Prevention
- DEVICE Transcranial Magnetic Stimulation: Sham
- DEVICE Transcranial Magnetic Stimulation: continuous theta burst to pre supplementary motor area
Study Locations (2)
Minnesota
- University of Minnesota - Minneapolis
Rhode Island
- Emma Pendleton Bradley Hospital - Riverside
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2024-03-20 |
| Est. Completion | 2026-07-31 |
| Phase | NA |
What NCT05931913 shows while recruiting
NCT05931913 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 2,064-participant average among 84 other Obsessive - Compulsive Disorder trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Obsessive - Compulsive Disorder appearing as the primary indexed condition, and to 4 interventions - of which Transcranial Magnetic Stimulation: intermittent theta burst to dorsolateral prefrontal cortex is the first listed.
NCT05931913 reports a single indexed study location in Minnesota, Rhode Island.
Frequently Asked Questions
What is clinical trial NCT05931913 about?
NCT05931913 is a clinical study titled "TMS + Exposure Therapy for Pediatric OCD". The goal of this clinical trial is to compare different forms of transcranial magnetic stimulation (TMS) for improving the outcomes of Exposure with Response Prevention (ERP) in youth and young adults with Obsessive-Compulsive Disorder (OCD). Researchers will compare three groups: ERP with one of tw...
What is the current status of trial NCT05931913?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2024-03-20. Estimated completion is 2026-07-31.
What conditions does trial NCT05931913 study?
This clinical trial studies the following conditions: Obsessive - Compulsive Disorder.
What interventions are being tested in trial NCT05931913?
The interventions under investigation include: Transcranial Magnetic Stimulation: intermittent theta burst to dorsolateral prefrontal cortex (DEVICE), Exposure with Response Prevention (BEHAVIORAL), Transcranial Magnetic Stimulation: Sham (DEVICE), Transcranial Magnetic Stimulation: continuous theta burst to pre supplementary motor area (DEVICE).
Who is sponsoring clinical trial NCT05931913?
This trial is sponsored by Bradley Hospital, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05931913 being conducted?
This trial has 2 study locations across Minnesota, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obsessive - Compulsive Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05931913's enrollment target sits among peer trials
60 39th of 84 higher than 45 of 84 other Obsessive - Compulsive Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obsessive - Compulsive Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Transcranial Magnetic Stimulation and Psychotherapy for Treating Obsessive-Compulsive Disorder
RECRUITING · NA
-
Mechanisms of Exposure Therapy for OCD
RECRUITING · NA
-
Using Personalized Assessments in the Treatment of Childhood OCD
RECRUITING · NA
-
Neural Mechanisms of Response Inhibition Training for OCRD
RECRUITING · NA
-
CO2 Reactivity as a Biomarker of Non-Response to Exposure-Based Therapy
RECRUITING · NA
-
Interpretation Bias as a Mechanism of Treatment Response in OCD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI